Annexon shares surge 26.88% intraday after director buys $5.05M in shares, signaling confidence in company’s outlook.

Annexon Inc. surged 26.88% intraday on November 20, 2025, driven by a combination of significant insider purchases, a public offering, and analyst upgrades. Director Muneer A. Satter acquired 1.5 million shares totaling $5.055 million over three days, signaling strong confidence in the company’s pipeline. This followed the completion of a $86.25 million public offering at $2.60 per share, enhancing liquidity and funding operations. Concurrently, Wells Fargo raised its price target to $27 from $14, reflecting optimism about Annexon’s neuroinflammation therapies and clinical milestones. The insider’s accumulation across multiple price tiers, coupled with the firm’s strategic fundraising and analyst upgrades, reinforced investor sentiment, propelling the stock’s sharp intraday rally.